# FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

> **NCT02715518** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 1292 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DEVICE:** PCI using 2nd generation drug-eluting stent

## Key facts

- **NCT ID:** NCT02715518
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-19
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 1292 (ACTUAL)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02715518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02715518, "FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02715518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*